News Release 

New cause of syndromic microcephaly identified

LMNB1 gene variants cause microcephaly by disrupting the nuclear envelope

Greenwood Genetic Center

Research News

Greenwood, SC (September 17, 2020) - Greenwood Genetic Center (GGC) researchers, in collaboration with scientists from Belgium, Spain, and Italy, have confirmed that variants in LMNB1 cause syndromic microcephaly with variable short stature, intellectual disability, and other neurological symptoms. The findings are reported in the October issue of the American Journal of Human Genetics.

The paper describes seven patients from five families with novel de novo variants in LMNB1, all with pronounced primary microcephaly as the core feature. Variants were identified through whole exome sequencing.

Functional analysis of each of the gene variants and resultant lamin B1 protein showed that these variants act in a dominant fashion to disrupt nuclear envelope integrity which in turn causes the nucleus to become misshapen.

"We used a HeLa cell system to analyze the three missense mutations in this gene and demonstrated impaired function of the nuclear lamina," said Tonya Moss, GGC research technologist and co-lead author along with Francesca Cristofoli, PhD, of University Hospitals Leuven in Belgium. "Two other variants displayed misshapen nuclei and a decrease in nuclear localization of the lamin B1 protein, and another showed an increased frequency of condensed nuclei."

Duplications in LMNB1 are a known cause of autosomal dominant adult-onset leukodystrophy, but this paper is the first to show that variants in this gene can cause congenital abnormalities through nuclear envelope disruption.

"Because this gene product has multiple domains, it is likely that different variants in LMNB1 will work by different mechanisms, necessitating a case-by-case analysis of pathogenicity, which is important for future treatment studies as well as reproductive planning for families," said Richard Steet, PhD, co-corresponding author and Director of Research at the JC Self Research Institute at GGC. "These findings add LMNB1 to the growing list of genes implicated in severe autosomal dominant microcephaly and broadens the phenotypic spectrum of the laminopathies."

###

About Greenwood Genetic Center

The Greenwood Genetic Center (GGC), founded in 1974, is a nonprofit organization advancing the field of medical genetics and caring for families impacted by genetic disease and birth defects. At its home campus in Greenwood, South Carolina, a talented team of physicians and scientists provides clinical genetic services, diagnostic laboratory testing, educational programs and resources, and research in the field of medical genetics. GGC's faculty and staff are committed to the goal of developing preventive and curative therapies for the individuals and families they serve. GGC extends its reach as a resource to all residents of South Carolina with satellite offices in Charleston, Columbia, Florence and Greenville. For more information about GGC please visit http://www.ggc.org.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.